Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Neoplasm, Residual 1

Interventions

palbociclib 2Trastuzumab 2Capecitabine 2trastuzumab deruxtecan 1tetrathiomolybdate 1sacituzumab govitecan 1pembrolizumab 1niraparib 1inavolisib 1giredestrant 1eribulin 1avelumab 1atezolizumab 1abemaciclib 1Zymosan 1Radiotherapy 1Letrozole 1Immunotherapy 1Hydroxychloroquine 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm, Residual × Zymosan × Breast × Clear all
NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Active not recruiting
35 enrolled
Breast

Neoplasm, Residual, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡